ENDRA Life Sciences Inc. Quarterly Return On Equity in % from Q3 2017 to Q2 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ENDRA Life Sciences Inc. quarterly/annual Return On Equity history and growth rate from Q3 2017 to Q2 2025.
  • ENDRA Life Sciences Inc. Return On Equity for the quarter ending June 30, 2025 was -283 %, a 74.1% decline year-over-year.
  • ENDRA Life Sciences Inc. annual Return On Equity for 2024 was -211 %, a 16.6% decline from 2023.
  • ENDRA Life Sciences Inc. annual Return On Equity for 2023 was -181 %, a 36.4% decline from 2022.
  • ENDRA Life Sciences Inc. annual Return On Equity for 2022 was -132 %, a 67.4% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2025 -283 -120 -74.1% Apr 1, 2025 Jun 30, 2025
Q1 2025 -196 -12 -6.54% Jan 1, 2025 Mar 31, 2025
Q4 2024 -211 -30 -16.6% Oct 1, 2024 Dec 31, 2024
Q3 2024 -141 +58.2 +29.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -162 +7.15 +4.22% Apr 1, 2024 Jun 30, 2024
Q1 2024 -184 -33.7 -22.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -181 -48.2 -36.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -200 -79.8 -66.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -170 -64.2 -60.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -151 -52 -52.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -132 -53.3 -67.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -120 -41.7 -53.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -105 -4.11 -4.06% Apr 1, 2022 Jun 30, 2022
Q1 2022 -98.5 +47 +32.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -79.1 +256 +76.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -78.1 +415 +84.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -101 +496 +83.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -146 +383 +72.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -335 +117 +25.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -493 -166 -50.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -598 -240 -67.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -528 -191 -56.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -451 -80.4 -21.7% Oct 1, 2019 Dec 31, 2019
Q3 2019 -327 +78.5 +19.3% Jul 1, 2019 Sep 30, 2019
Q2 2019 -358 -175 -95.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -337 -208 -160% Jan 1, 2019 Mar 31, 2019
Q4 2018 -371 -257 -225% Oct 1, 2018 Dec 31, 2018
Q3 2018 -406 -287 -241% Jul 1, 2018 Sep 30, 2018
Q2 2018 -183 Apr 1, 2018 Jun 30, 2018
Q1 2018 -129 Jan 1, 2018 Mar 31, 2018
Q4 2017 -114 Oct 1, 2017 Dec 31, 2017
Q3 2017 -119 Jul 1, 2017 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.